i-Base home
Search Menu
  • Home
  • HTB
  • ICAAC 46th San Francisco 2006

ICAAC 46th San Francisco 2006

46th Interscience Conference on Antiretroviral Agents and Chemotherapy (ICAAC), 27-30 September 2006, San Francisco

7 October 2006. Related: Conference reports.

MK-0518 demonstrates potent efficacy in patients with triple-class resistant virus: 24 week results

7 October 2006. Related: Conference reports, Drug resistance.

Lipid profile of integrase inhibitor MK-0518: 24 week results compared to efavirenz in treatment naive patients

7 October 2006. Related: Conference reports, Antiretrovirals.

HIV may use different coreceptors in blood and brain

7 October 2006. Related: Conference reports, Basic science and immunology.

Critical interactions between darunavir (TMC114), lopinavir, Viagra, and oral contraceptives

7 October 2006. Related: Conference reports, PK and drug interactions.

NRTI elvucitabine active against HIV in a 7-day monotherapy study

7 October 2006. Related: Conference reports, Antiretrovirals.

Efavirenz/tenofovir fails as 2-drug maintenance regimen

7 October 2006. Related: Conference reports, Antiretrovirals.

Nucleoside inhibitor MK-0608 mediates suppression of HCV replication for >30 days in chronically infected chimpanzees

7 October 2006. Related: Conference reports, Hepatitis coinfection.

  • HTB RSS

Early access

  • Vaccination effectively limits mpox progression: lower efficacy in people living with HIV 27 May 2025
  • US update guidelines for statin use in people living with HIV 26 May 2025
  • HIV activists in the US call for action and Zachie Achmet brings South African perspective 26 May 2025
  • Scientific, legal and ethical crisis from halting ongoing NIH studies: TAG statement 22 May 2025
  • All early access reports

Current issues

  • May 2025
  • April 2025
  • March 2025
  • Back issues

Special report

  • Scientific, legal and ethical crisis from halting ongoing NIH studies: TAG statement 22 May 2025

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage
  • Donate

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
Registered charity number: 1081905. Company number: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Donate
Feedback
Advice and information
Q and A
Guides
HIV meds
Glossary
Research reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
News and updates
Sitemap
Home
Find us on Facebook
i-Base on Facebook